Aimei Health Technology (AFJKR) Liabilities and Shareholders Equity (2023 - 2025)

Aimei Health Technology (AFJKR) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $12.1 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity fell 83.6% year-over-year to $12.1 million; the TTM figure through Dec 2025 stood at $145.7 million (down 49.71% YoY), while the FY2025 annual figure was $12.1 million, down 83.6% from the prior year.
• Liabilities and Shareholders Equity eased to $12.1 million in Q4 2025 per AFJKR's latest filing, from $45.5 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $73.8 million in Q4 2024 and bottomed at $12.1 million in Q4 2025.
• Historically, Liabilities and Shareholders Equity has averaged $56.2 million across 3 years, with a median of $70.5 million in 2023.
• Annual changes were most pronounced in 2024 — Liabilities and Shareholders Equity climbed 4.75% — and 2025, when it slumped 83.6%.
• Aimei Health Technology's Liabilities and Shareholders Equity stood at $70.5 million in 2023, then gained by 4.75% to $73.8 million in 2024, then plunged by 83.6% to $12.1 million in 2025.
• Business Quant data shows AFJKR's Liabilities and Shareholders Equity at $12.1 million in Q4 2025, $45.5 million in Q3 2025, and $44.6 million in Q2 2025.